Indication
Dyschromia
Dyschromia refers to any abnormal alteration or irregularity in the pigmentation of the skin, hair, or nails, primarily affecting the integumentary system. Read more about Dyschromia
32 drugs 15 manufacturers
Drugs that treat it
Common Dyschromia therapies.
HYDROQUINONE (hydroquinone microspheres)
HYDROQUINONE
HYDROQUINONE
ESOTERICA FADE CREAM (hydroquinone)
HYDROQUINONE
HYDROQUINONE
C-CLARIFYING SERUM (hydroquinone/ascorbic acid)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDyschromia refers to any abnormal alteration or irregularity in the pigmentation of the skin, hair, or nails, primarily affecting the integumentary system.
It encompasses hyperpigmentation, hypopigmentation, complete depigmentation, or mottled patterns characterized by concurrent hyper- and hypopigmented macules.
Pathophysiologically, the condition arises from disturbances in melanocyte density, melanin synthesis, or melanosome transfer, which may be triggered by ultraviolet radiation, hormonal fluctuations, cutaneous inflammation, genetic anomalies, or exogenous chemical exposures.
Although dyschromia can manifest across all demographic groups, it is especially common, prominent, and persistent in individuals with darker skin phototypes.
- wikipedia.org
Dyschromia refers to any abnormal alteration or irregularity in the pigmentation of the skin, hair, or nails, primarily affecting the integumentary system It encompasses hyperpigmentation, hypopigmentation, complete depigmentation, or mottled patterns characterized by concurrent hyper- and hypopigmented macules
- stemcellreference.com
Dyschromia refers to any abnormal alteration or irregularity in the pigmentation of the skin, hair, or nails, primarily affecting the integumentary system
- nih.gov
It encompasses hyperpigmentation, hypopigmentation, complete depigmentation, or mottled patterns characterized by concurrent hyper- and hypopigmented macules Although dyschromia can manifest across all demographic groups, it is especially common, prominent, and persistent in individuals with darker skin phototypes
- nih.gov
It encompasses hyperpigmentation, hypopigmentation, complete depigmentation, or mottled patterns characterized by concurrent hyper- and hypopigmented macules Pathophysiologically, the condition arises from disturbances in melanocyte density, melanin synthesis, or melanosome transfer, which may be triggered by ultraviolet radiation, hormonal fluctuations, cutaneous inflammation, genetic anomalies, or exogenous chemical exposures
- nih.gov
Pathophysiologically, the condition arises from disturbances in melanocyte density, melanin synthesis, or melanosome transfer, which may be triggered by ultraviolet radiation, hormonal fluctuations, cutaneous inflammation, genetic anomalies, or exogenous chemical exposures
- nih.gov
Pathophysiologically, the condition arises from disturbances in melanocyte density, melanin synthesis, or melanosome transfer, which may be triggered by ultraviolet radiation, hormonal fluctuations, cutaneous inflammation, genetic anomalies, or exogenous chemical exposures Although dyschromia can manifest across all demographic groups, it is especially common, prominent, and persistent in individuals with darker skin phototypes
- nih.gov
Although dyschromia can manifest across all demographic groups, it is especially common, prominent, and persistent in individuals with darker skin phototypes
Personalize your experience
Follow Dyschromia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.